comparemela.com

Latest Breaking News On - Hedge funds weigh in on jazz pharmaceuticals - Page 1 : comparemela.com

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CAO Patricia Carr Sells 163 Shares

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) CAO Patricia Carr sold 163 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $108.83, for a total value of $17,739.29. Following the transaction, the chief accounting officer now owns 6,596 shares in the company, […]

Analysts Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195 08

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average […]

StockNews com Lowers Jazz Pharmaceuticals (NASDAQ:JAZZ) to Buy

StockNews.com downgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) from a strong-buy rating to a buy rating in a report issued on Thursday morning. Other analysts have also issued reports about the stock. Cantor Fitzgerald reiterated an overweight rating and issued a $180.00 price target on shares of Jazz Pharmaceuticals in a research report […]

Barclays Trims Jazz Pharmaceuticals (NASDAQ:JAZZ) Target Price to $200 00

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price target dropped by equities research analysts at Barclays from $230.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 82.08% […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.